ERBB2 and neoplasm: Among them, the majority of cases with ER positivity were associated with low tumor budding, and it was statistically significant (p = 0.04), while the other IHC marker HER2/neu was not found to be statistically significant with high tumor budding as most of the HER2neu negative patients were also associated with high tumor budding.